INNOV17 LLC
Records under this name other than patents INNOV17 LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to INNOV17 LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,884,847 | Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof Lapsed on the fee record Ended Feb 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 6, 2026 | From the USPTO record |
| US 9,771,374 | Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof Lapsed on the fee record Ended Sep 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2025 | From the USPTO record |
| US 9,708,268 | ROR modulators and their uses Lapsed on the fee record Ended Jul 18, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2025 | From the USPTO record |
| US 9,701,663 | Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof Lapsed on the fee record Ended Jul 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 11, 2025 | From the USPTO record |
| US 9,447,069 | ROR modulators and their uses Lapsed on the fee record Ended Sep 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2020 | From the USPTO record |
| US 9,321,750 | ROR modulators and their uses Lapsed on the fee record Ended Apr 26, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2020 | From the USPTO record |